129 related articles for article (PubMed ID: 26739480)
1. Hypothermia Associated With Thioridazine Use in an Intellectually Disabled Patient.
Goodbar NH; Foushee JA; Nash K; Connolly LA; Webster LM
J Pharm Pract; 2016 Jun; 29(3):250-2. PubMed ID: 26739480
[TBL] [Abstract][Full Text] [Related]
2. Mild Hypothermia in a Child with Low-Dose Risperidone.
Grau K; Plener PL; Gahr M; Denzer C; Freudenmann RW
Z Kinder Jugendpsychiatr Psychother; 2017 Jul; 45(4):335-337. PubMed ID: 27685194
[TBL] [Abstract][Full Text] [Related]
3. Thioridazine: re-evaluating the risk/benefit equation.
Timell AM
Ann Clin Psychiatry; 2000 Sep; 12(3):147-51. PubMed ID: 10984004
[TBL] [Abstract][Full Text] [Related]
4. Possible long-acting risperidone-induced hypothermia precipitating phenytoin toxicity in an elderly patient.
Brandon Bookstaver P; Miller AD
J Clin Pharm Ther; 2011 Jun; 36(3):426-9. PubMed ID: 21545623
[TBL] [Abstract][Full Text] [Related]
5. Profound hypothermia secondary to normal ziprasidone use.
Gibbons GM; Wein DA; Paula R
Am J Emerg Med; 2008 Jul; 26(6):737.e1-2. PubMed ID: 18606348
[TBL] [Abstract][Full Text] [Related]
6. Hypothermic coma associated with thioradizine in a myxedematous patient.
Lanska D; Harsch HH
J Clin Psychiatry; 1984 Apr; 45(4):188-9. PubMed ID: 6715297
[No Abstract] [Full Text] [Related]
7. Effects of thioridazine and withdrawal dyskinesias on workshop performance of mentally retarded young adults.
Breuning SE; Davis VJ; Matson JL; Ferguson DG
Am J Psychiatry; 1982 Nov; 139(11):1447-54. PubMed ID: 6753612
[TBL] [Abstract][Full Text] [Related]
8. Effect of olanzapine on disruptive behavior in institutionalized patients with severe intellectual disability--a case series.
Drmić S; Franić T
Coll Antropol; 2008 Jun; 32(2):325-30. PubMed ID: 18756876
[TBL] [Abstract][Full Text] [Related]
9. Corneal and lenticular opacities in mentally retarded young adults treated with thioridazine and chlorpromazine.
Gualtieri CT; Lefler WH; Guimond M; Staye JI
Am J Psychiatry; 1982 Sep; 139(9):1178-80. PubMed ID: 7114312
[TBL] [Abstract][Full Text] [Related]
10. [Polymorphic ventricular tachycardia of torsade de pointes type in patient with schizophrenia treated with thioridazine].
Sinkiewicz W; Balak W; Fares I; Karasek D; Małyszka P; Papke M
Pol Arch Med Wewn; 2006 Dec; 116(6):1188-91. PubMed ID: 18634530
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for hypothermia in psychiatric patients.
Young DM
Ann Clin Psychiatry; 1996 Jun; 8(2):93-7. PubMed ID: 8807034
[TBL] [Abstract][Full Text] [Related]
12. Five cases of pigmentary retinopathy associated with thioridazine administration.
Hagopian V; Stratton DB; Busiek RD
Am J Psychiatry; 1966 Jul; 123(1):97-100. PubMed ID: 5935198
[No Abstract] [Full Text] [Related]
13. Progressive severe visual loss after long-term withdrawal from thioridazine treatment.
Chaudhry IA; Shamsi FA; Weitzman ML
Eur J Ophthalmol; 2006; 16(4):651-3. PubMed ID: 16952115
[TBL] [Abstract][Full Text] [Related]
14. [The new draft law on care and coercion. Concerning the use and the reduction of antipsychotics without a valid indication in people with intellectual disabilities].
Kapitein S; Wieland J
Tijdschr Psychiatr; 2014; 56(12):807-15. PubMed ID: 25510455
[TBL] [Abstract][Full Text] [Related]
15. Atypical antipsychotic induced mild hypothermia.
Brevik A; Farver D
S D J Med; 2003 Feb; 56(2):67-70. PubMed ID: 12621956
[TBL] [Abstract][Full Text] [Related]
16. Effects of controlled discontinuation of long-term used antipsychotics on weight and metabolic parameters in individuals with intellectual disability.
de Kuijper G; Mulder H; Evenhuis H; Visser F; Hoekstra PJ
J Clin Psychopharmacol; 2013 Aug; 33(4):520-4. PubMed ID: 23775048
[TBL] [Abstract][Full Text] [Related]
17. Cardiotoxicity and prescription of thioridazine in New Zealand.
Menkes DB; Knight JC
Aust N Z J Psychiatry; 2002 Aug; 36(4):492-8. PubMed ID: 12169148
[TBL] [Abstract][Full Text] [Related]
18. Effects of discontinuation of long-term used antipsychotics on prolactin and bone turnover markers in patients with intellectual disability.
de Kuijper GM; Mulder H; Evenhuis H; Visser F; Hoekstra PJ
J Clin Psychopharmacol; 2014 Feb; 34(1):157-9. PubMed ID: 24135841
[No Abstract] [Full Text] [Related]
19. Effects of controlled discontinuation of long-term used antipsychotics for behavioural symptoms in individuals with intellectual disability.
de Kuijper G; Evenhuis H; Minderaa RB; Hoekstra PJ
J Intellect Disabil Res; 2014 Jan; 58(1):71-83. PubMed ID: 23046144
[TBL] [Abstract][Full Text] [Related]
20. Outcome of patients after market withdrawal of thioridazine: a retrospective analysis in a nationwide cohort.
Purhonen M; Koponen H; Tiihonen J; Tanskanen A
Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1227-31. PubMed ID: 22941581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
